June 4, 2018 · STOCK Act disclosure
Senator James M. Inhofe (Republican-OK) sold Bristol-Myers Squibb Company, a stock transaction, valued at $50,001 - $100,000. The trade took place on June 4, 2018 and was disclosed on June 20, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.
Bristol-Myers Squibb Company